LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Geschlossen

5.01

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

5.01

Max

5.01

Schlüsselkennzahlen
By Trading Economics
Einkommen	1.3M -3M
Verkäufe	100K 100K
Gewinnspanne	-2,954
Angestellte	21

Dividenden
By Dow Jones
Nächstes Ergebnis	7. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-208K 39M
Vorheriger Eröffnungskurs	5.01
Vorheriger Schlusskurs	5.01

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

27. März 2026, 17:33 UTC

Wichtige Nachrichtenereignisse

ECB Should Not Rush Its Response to Iran Conflict, Says Schnabel -- Update

27. März 2026, 17:00 UTC

Wichtige Nachrichtenereignisse

ECB Shouldn't Rush Its Response to Iran Conflict, Schnabel Says

27. März 2026, 16:03 UTC

Wichtige Nachrichtenereignisse

Fertilizer Maker Yara Warns Farmers Are Being Squeezed by Price Surge Amid War -- Commodities Roundup

29. März 2026, 23:47 UTC

Market Talk

Wichtige Nachrichtenereignisse

Gold Falls Amid Rising Inflation Fears -- Market Talk

29. März 2026, 23:46 UTC

Market Talk

Wichtige Nachrichtenereignisse

Nikkei May Fall on Fears About Shortage of Petrochemical Products -- Market Talk

29. März 2026, 23:35 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Rises on Supply-Disruption Concerns Spurred by Widening Mideast Conflict -- Market Talk

29. März 2026, 23:23 UTC

Market Talk

Australia's National Cabinet to Avoid Covid-Style Measures -- Market Talk

29. März 2026, 22:34 UTC

Market Talk

Macroeconomic Tailwind for Warehouse Dissipates -- Market Talk

29. März 2026, 22:09 UTC

Market Talk

Amplitude's Next Well "Effectively a Must-Win" for Growth Thesis -- Market Talk

29. März 2026, 21:06 UTC

Market Talk

Wichtige Nachrichtenereignisse

Australia's Economy Could Already Be Contracting Amid Oil Shock -- Market Talk

29. März 2026, 21:03 UTC

Market Talk

Australia's Government Wants to Avoid Heavy Handed Oil Shock Response -- Market Talk

29. März 2026, 21:01 UTC

Market Talk

Wichtige Nachrichtenereignisse

Australian National Cabinet Meeting to Focus on Oil Supply -- Market Talk

29. März 2026, 09:30 UTC

Akquisitionen, Fusionen, Übernahmen

Food Mega-Mergers Hardly Ever Work. Could McCormick-Unilever Be Different? -- Heard on the Street -- WSJ

28. März 2026, 08:20 UTC

Market Talk

Health Care Roundup: Market Talk

27. März 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27. März 2026, 19:16 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Futures Rise On Uncertainty Ahead of Weekend -- Market Talk

27. März 2026, 19:07 UTC

Market Talk

U.S. Natural Gas Gains As April Contract Expires -- Market Talk

27. März 2026, 19:04 UTC

Market Talk

Gold Rises But Can't Finish the Week Positive -- Market Talk

27. März 2026, 19:03 UTC

Market Talk

Wichtige Nachrichtenereignisse

Global Forex and Fixed Income Roundup: Market Talk

27. März 2026, 19:02 UTC

Market Talk

Wichtige Nachrichtenereignisse

Among Central Banks, Canada Has Room to Handle Oil Inflation -- Market Talk

27. März 2026, 18:12 UTC

Market Talk

Foreign Fuels and Feedstocks to Get RINs Until 2028 -- Market Talk

27. März 2026, 17:36 UTC

Wichtige Nachrichtenereignisse

The Iran War and Oil Prices Bring Risk of Deeper Market Lows. There Are Echoes of 2008. -- Barrons.com

27. März 2026, 17:34 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Delivery Hero Shares Bounce as Stake-Sale Report Whets Investor Appetites -- Market Talk

27. März 2026, 17:29 UTC

Market Talk

U.S. Oil Rig Count Falls By 5 to 409 -- Market Talk

27. März 2026, 16:38 UTC

Market Talk

Carnival's Outlook Assumes Oil Prices Will Come Down -- Market Talk

27. März 2026, 16:32 UTC

Market Talk

Wichtige Nachrichtenereignisse

Chinese Exposure to Higher Energy Costs Seen as Limited -- Market Talk

27. März 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

27. März 2026, 15:43 UTC

Market Talk

Wichtige Nachrichtenereignisse

Hormuz Closure Sends Tanker Rates to Record Highs -- Market Talk

27. März 2026, 15:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27. März 2026, 15:25 UTC

Market Talk

Swiss Franc Dented by Rising European Yields, SNB Intervention Threats -- Market Talk

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.